Biopharmaceuticals
Immunome is developing first-in-class cancer therapies by unlocking the tumor-educated B cell response from patients. Their proprietary discovery engine identifies antibody-target pairs by interrogating the patient response with unparalleled depth, breadth, and speed. Using this rich source of antibody-target pairs, Immunome is developing new cancer therapies and exploring vast, untapped areas of cancer biology.
Purnanand Sarma, Ph.D.
Nice Insight/That’s Nice
89 Fifth AvenueFifth FloorNew YorkNY 10003-3020
New York – San Diego – ChicagoLondon – Frankfurt – Shanghai
Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.